Ensifentrine, an investigational medication under review in the U.S. for chronic obstructive pulmonary disease (COPD), is effective across key…
Articles by Lindsey Shapiro PhD
Increases in new onset or recurring depression were seen among older Canadian adults with chronic obstructive pulmonary disease (COPD)…
Tiotropium bromide dry inhalation powder for use with the LupinHaler device, a generic version of Spiriva…
Breyna, a generic version of Symbicort (budesonide-formoterol), has been launched in the U.S. for eligible people with chronic…
Lower vitamin D levels in the blood are associated with an increased risk of chronic obstructive pulmonary disease (COPD),…
People with diabetes or prediabetes are at an increased risk of developing chronic obstructive pulmonary disease (COPD), according to…
Pneumagen has secured £8 million (nearly $10 million) in investments to support the clinical development of its nasal spray,…
Dupixent (dupilumab) — a medication initially approved for exzema — was found to significantly reduce the number of disease exacerbations…
Therapeutic Solutions International (TSOI) reported discovering a new mechanism of action for JadiCell, its investigative stem cell therapy…
Chronic obstructive pulmonary disease (COPD) was associated with an increased risk of overall mortality, as well as higher chances…